US2020087609A1PendingUtilityA1

Removal of microorganisms from cell culture media

Assignee: EMD MILLIPORE CORPPriority: Dec 22, 2014Filed: Nov 19, 2019Published: Mar 19, 2020
Est. expiryDec 22, 2034(~8.4 yrs left)· nominal 20-yr term from priority
B01D 65/08C08F 222/38B01D 2323/36C12N 5/0018B01D 71/68C08J 2381/06B01D 2323/40B01D 61/14C12M 37/02B01D 67/009B01D 67/0088B01D 2323/30B01D 2325/20C07K 1/34C08J 7/18B01D 71/82A61L 2/022B01D 67/0093A61L 2/0017A61L 2103/05
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions and methods are provided for removing viral contaminants from a chemically defined cell culture medium. Compositions provided herein are resistant to or exhibit reduced fouling by one or more components in a chemically defined cell culture medium.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of removing one or more viral contaminants from a chemically defined cell culture medium, the method comprising:
 a. providing a chemically defined cell culture medium; and   b. filtering the chemically defined cell culture medium through a porous membrane, prior to or during transfer of the medium into a bioreactor, wherein the porous membrane is a PES membrane, a PVDF membrane, or a cellulosic membrane and wherein the porous membrane has a surface treatment comprising a cross-linked polymer, the cross-linked polymer comprising a diacetone acrylamide and one or more non-acrylamides;   
       wherein the level of one or more viral contaminants in the chemically defined cell culture medium inside the bioreactor is lower than the level prior to filtering the medium through the membrane. 
     
     
         2 . The method of  claim 1 , wherein the porous membrane is an asymmetric membrane. 
     
     
         3 . The method of  claim 1 , wherein the one or more non-acrylamides is polyethylene glycol diacrylate. 
     
     
         4 . The method of  claim 1 , wherein the polymer is directly coated on a surface of the porous membrane using an energy source. 
     
     
         5 . The method of  claim 4 , wherein the energy source is selected from the group consisting of heat, electron beam, ultraviolet light and gamma radiation. 
     
     
         6 . The method of  claim 1 , wherein the porous membrane is incorporated into a device. 
     
     
         7 . The method of  claim 6 , wherein the device is in a format selected from a disc, a pleated cartridge, a spirally wound cartridge, and a multi-plate flat sheet. 
     
     
         8 . The method of  claim 1 , wherein the chemically defined cell culture medium is selected from the group consisting of Lonza Power CHO, CD Opti CHO, EMD Millipore Cellvento CHO 100 and Cellvento CHO 200. 
     
     
         9 . The method of  claim 1 , wherein level of one or more viral contaminants following step (b) is reduced by at least 1 Log 10  reduction value (LRV) or at least 4 Log 10  reduction value (LRV) or at least 6 Log 10  reduction value (LRV). 
     
     
         10 . The method of  claim 1 , wherein the filtering step is carried out for a period of less than 24 hours. 
     
     
         11 . The method of  claim 1 , wherein the filtering step is conducted at a temperature ranging from 20° C. to 25° C. 
     
     
         12 . The method of  claim 1 , wherein a normal flow filtering step is conducted at a temperature ranging from 20° C. to 25° C. 
     
     
         13 . The method of  claim 1 , wherein the filtering step is conducted at a pH ranging from 4 to 8. 
     
     
         14 . A method of reducing the fouling of a virus retentive membrane by one or more components in a chemically defined cell culture medium during filtration, the method comprising:
 a. providing a virus retentive membrane; and   b. modifying a surface of the virus retentive membrane with a polymer comprising crosslinked monomers of diacetone acrylamide and one or more non-acrylamides monomers,   
       wherein the fouling of the modified membrane by one or more components in a chemically defined cell culture medium is reduced relative to an unmodified membrane. 
     
     
         15 . The method of  claim 14 , wherein the virus retentive membrane is a PES membrane, a PVDF membrane, a cellulosic membrane or a nylon membrane. 
     
     
         16 . The method of  claim 14 , wherein the one or more non-acrylamide monomer is PEGDA.

Join the waitlist — get patent alerts

Track US2020087609A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.